Sort
21,281 grants matching “influenza”
Recombinant Yellow Fever 17D-Lassa Vaccine
$535,411Igor S. Lukashevich · University Of Maryland Baltimore · R01 · FY2008 · AI
Mechanistic evaluation of the role of circadian rhythms in acute lung injury and subsequent recovery
$535,306Shaon Sengupta · Children'S Hosp Of Philadelphia · R01 · FY2025 · HL
Interferon-induced IFITM recruitment of ZMPSTE24 blocks viral endocytic entry
$535,280Martin E Dorf · Harvard Medical School · R01 · FY2016 · AI
An Integrated Multilevel Modeling Framework for Repertoire-Based Diagnostics
$535,171Ramy Arnaout · Beth Israel Deaconess Medical Center · R01 · FY2020 · AI
Risk of Viral Emergence from Bats
$535,156Peter Daszak · Ecohealth Alliance, Inc. · R01 · FY2009 · AI
Engineered âmuco-trappingâ antibodies for inhaled therapy of parainfluenza and human metapneumovirus infections
$535,133Samuel Lai · Univ Of North Carolina Chapel Hill · R01 · FY2025 · AI
Investigating Transplacental Immune Pathways Contributing to Fetal Brain Pathology in Maternal Influenza
$535,039Adrienne M Antonson · University Of Illinois At Urbana-Champaign · R01 · FY2025 · HD
Influenza & COVID Obstetric and Perinatal Epidemiology Study in India
$534,998Patricia L Hibberd · Boston University Medical Campus · R01 · FY2023 · HD
Risk of Viral Emergence from Bats
$534,989Peter Daszak · Ecohealth Alliance, Inc. · R01 · FY2008 · AI
Task A15: Mouse Models for Evaluation of Influenza Vaccines and Adjuvants
$534,866Utah State University · N01 · FY2012 · AI
ISS-linked NP vaccine to control pandemic flu outbreak
$534,847Dynavax Technologies Corporation · U01 · FY2005 · AI
Deciphering long-term virus evolution through the reconstruction of past viral genomes
$534,762Daniel Blanco-Melo · Fred Hutchinson Cancer Center · DP2 · FY2023 · AI
DNA Vaccine for Induction of Mucosal Immunity
$534,596David B. Weiner · University Of Pennsylvania · P01 · FY2009 · AI
Vaccine-Induced memory CD4T cells and HIV reservoirs
$534,432Savita Pahwa · University Of Miami School Of Medicine · R56 · FY2013 · AI
Task A30: Mouse Models for Evaluation of Therapeutics against Human Seasonal Influenza and Avian Influenza Strains with Pandemic Potential
$534,397John Morrey · Utah State University · N01 · FY2019 · AI
A 3D human tissue-engineered lung model to study immune responses to Respiratory Syncytial Virus
$534,158Susan Kovats · Oklahoma Medical Research Foundation · R01 · FY2020 · EB
Protein Expression/Dengue Virology Core
$534,138Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U19 · FY2018 · AI
WAVE Regulatory Complex in Primary Immunodeficiency Disease and autoimmunity
$534,041Brian M Iritani · University Of Washington · R01 · FY2022 · AI
Determining Influenza Vaccine Effectiveness (DIVE)
$533,970Helen Keipp Talbot · Vanderbilt University Medical Center · U01 · FY2019 · IP
Targeting TLR Signaling Pathways to Blunt Pathogen-mediated Acute Lung Injury
$533,933Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2018 · AI
Targeting TLR Signaling Pathways to Blunt Pathogen-mediated Acute Lung Injury
$533,933Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2020 · AI
Targeting TLR Signaling Pathways to Blunt Pathogen-mediated Acute Lung Injury
$533,933Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2019 · AI
Studies on RNAi Based Delivery in Vivo
$533,921Mark A Kay · Stanford University · R01 · FY2012 · DK
Roles of tissue-resident helper T cells in mucosal immunity against influenzainfection
$533,722Jie Sun · University Of Virginia · R01 · FY2024 · AI
Epigenetic Plasticity of HCV-Specific CD8 T Cells after Antiviral Therapy
$533,673William Nicholas Haining · Massachusetts General Hospital · U19 · FY2016 · AI